Tahara; Hidetoshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tahara; Hidetoshi.The latest application filed is for "therapeutic pharmaceutical composition for cancer including mirna".

Company Profile

7.6.17

Tahara; Hidetoshi - Hiroshima JP
TAHARA; Hidetoshi - Hiroshima-shi JP
Tahara; Hidetoshi - Hiroshima-Ken JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Therapeutic Pharmaceutical Composition For Cancer Including Mirna App 20220218733 - Tahara; Hidetoshi ; et al.	2022-07-14
Therapeutic Pharmaceutical Composition For Cancer Including Mirna App 20220202848 - Tahara; Hidetoshi ; et al.	2022-06-30
Therapeutic pharmaceutical composition for cancer including miRNA Grant 11,311,568 - Tahara , et al. April 26, 2	2022-04-26
Method For Assisting In Detection Of Breast Cancer App 20210079478 - TAHARA; Hidetoshi ; et al.	2021-03-18
Method For Assisting Detection Of Head And Neck Cancer App 20210071259 - TAHARA; Hidetoshi ; et al.	2021-03-11
Compound Which Inhibits Telomere-binding Protein, And Telomere-binding Protein Inhibitor Containing Same App 20210024455 - TAHARA; Hidetoshi ; et al.	2021-01-28
Aging Condition Evaluation Method, Information Presentation Method, And Screening Method For Substance That Improves Or Prevents Aging Condition App 20200386771 - Kan; Kaen ; et al.	2020-12-10
Method For Assisting Detection Of Alzheimer's Disease Or Mild Cognitive Impairment App 20200332361 - TAHARA; Hidetoshi ; et al.	2020-10-22
Therapeutic Pharmaceutical Composition For Cancer Including Mirna App 20200254001 - Kind Code	2020-08-13
Method for assisting detection of alzheimer'S disease or mild cognitive impairment Grant 10,738,360 - Tahara , et al. A	2020-08-11
Method for determination of the length of the G-tail sequence and kit for the method Grant 9,932,627 - Tahara , et al. April 3, 2	2018-04-03
Method For Assisting Detection Of Alzheimer's Disease Or Mild Cognitive Impairment App 20180067132 - TAHARA; Hidetoshi ; et al.	2018-03-08
Method for assisting detection of pancreatic cancer Grant 9,909,190 - Tahara , et al. March 6, 2	2018-03-06
Method For Assisting Detection Of Pancreatic Cancer App 20170073764 - TAHARA; Hidetoshi ; et al.	2017-03-16
Assay Method And Kit For Nucleic Acid Binding Protein App 20170044597 - TAHARA; Hidetoshi ; et al.	2017-02-16
Aging marker, method for evaluating aging inhibitor, and cancer inhibitor Grant 9,222,089 - Tahara December 29, 2	2015-12-29
Aging Marker, Method For Evaluating Aging Inhibitor, And Cancer Inhibitor App 20140088173 - TAHARA; Hidetoshi	2014-03-27
Senescence Marker, Method For Evaluating Senescence Inhibitor, And Cancer Inhibitor App 20120315640 - Tahara; Hidetoshi	2012-12-13
Method For Determination Of The Length Of The G-tail Sequence And Kit For The Method App 20120190022 - Tahara; Hidetoshi ; et al.	2012-07-26
Assay Method And Kit For Nucleic Acid Binding Protein App 20110033951 - Tahara; Hidetoshi ; et al.	2011-02-10
Method For Determination Of The Length Of The G-tail Sequence And Kit For The Method App 20090298062 - Tahara; Hidetoshi ; et al.	2009-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.